Lensar Inc Financials

LNSR

Source SEC Filings (10-K/10-Q) Updated Sep 30, 2025 Currency USD FYE December

Financial Health Signals

Financial Profile 38/100

Based on FY2024 annual data. Scores normalized against common benchmarks. How we calculate these scores

Profitability

Lensar Inc has an operating margin of -19.9%, meaning the company retains $-20 of operating profit per $100 of revenue. This below-average margin results in a low score of 0/100, suggesting thin profitability after operating expenses. This is up from -29.0% the prior year.

Growth

100

Lensar Inc's revenue surged 26.9% year-over-year to $53.5M, reflecting rapid business expansion. This strong growth earns a score of 100/100.

Leverage

Lensar Inc has elevated debt relative to equity (D/E of 12.64), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 0/100, reflecting increased financial risk.

Liquidity

With a current ratio of 2.80, Lensar Inc holds $2.80 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 92/100.

Cash Flow

While Lensar Inc generated -$2.3M in operating cash flow, capex of $156K consumed most of it, leaving -$2.4M in free cash flow. This results in a low score of 0/100, reflecting heavy capital investment rather than weak cash generation.

Piotroski F-Score Weak

2/9

Lensar Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 efficiency signals pass.

Earnings Quality Low Quality

0.07x

For every $1 of reported earnings, Lensar Inc generates $0.07 in operating cash flow (-$2.3M OCF vs -$31.4M net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

This page shows Lensar Inc (LNSR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 6 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Export CSV

Key Financial Metrics

Revenue

$53.5M

YoY+26.9%

5Y CAGR+11.9%

Lensar Inc generated $53.5M in revenue in fiscal year 2024. This represents an increase of 26.9% from the prior year.

EBITDA

-$6.7M

YoY+22.7%

Lensar Inc's EBITDA was -$6.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 22.7% from the prior year.

Free Cash Flow

-$2.4M

YoY+75.4%

Lensar Inc generated -$2.4M in free cash flow in fiscal year 2024, representing cash available after capex. This represents an increase of 75.4% from the prior year.

Net Income

-$31.4M

YoY-118.3%

Lensar Inc reported -$31.4M in net income in fiscal year 2024. This represents a decrease of 118.3% from the prior year.

EPS (Diluted)

$-2.73

YoY-108.4%

Lensar Inc earned $-2.73 per diluted share (EPS) in fiscal year 2024. This represents a decrease of 108.4% from the prior year.

Cash & Debt

$16.3M

YoY-21.1%

5Y CAGR+28.6%

Lensar Inc held $16.3M in cash against $0 in long-term debt as of fiscal year 2024.

Dividends Per Share

N/A

Shares Outstanding

12M

YoY+4.1%

Lensar Inc had 12M shares outstanding in fiscal year 2024. This represents an increase of 4.1% from the prior year.

Gross Margin

48.3%

YoY-1.7pp

5Y CAGR+5.0pp

Lensar Inc's gross margin was 48.3% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 1.7 percentage points from the prior year.

Operating Margin

-19.9%

YoY+9.1pp

5Y CAGR+21.7pp

Lensar Inc's operating margin was -19.9% in fiscal year 2024, reflecting core business profitability. This is up 9.1 percentage points from the prior year.

Net Margin

-58.7%

YoY-24.6pp

5Y CAGR-10.7pp

Lensar Inc's net profit margin was -58.7% in fiscal year 2024, showing the share of revenue converted to profit. This is down 24.6 percentage points from the prior year.

Return on Equity

N/A

R&D Spending

$5.3M

YoY-13.2%

5Y CAGR-6.8%

Lensar Inc invested $5.3M in research and development in fiscal year 2024. This represents a decrease of 13.2% from the prior year.

Share Buybacks

N/A

Capital Expenditures

$156K

YoY-33.9%

5Y CAGR-16.7%

Lensar Inc invested $156K in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 33.9% from the prior year.

LNSR Income Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Revenue	$53.5M+26.9%	$42.2M+19.2%	$35.4M+2.6%	$34.5M+30.6%	$26.4M-13.6%	$30.5M
Cost of Revenue	$27.6M+31.3%	$21.1M+36.7%	$15.4M-7.4%	$16.6M+35.1%	$12.3M-28.9%	$17.3M
Gross Profit	$25.9M+22.5%	$21.1M+5.8%	$20.0M+11.9%	$17.8M+26.7%	$14.1M+6.4%	$13.2M
R&D Expenses	$5.3M-13.2%	$6.1M-48.0%	$11.8M-4.4%	$12.4M+63.6%	$7.6M-0.2%	$7.6M
SG&A Expenses	$26.5M+1.5%	$26.1M-3.9%	$27.2M+13.7%	$23.9M+0.5%	$23.8M+38.6%	$17.1M
Operating Income	-$10.7M+12.8%	-$12.2M+39.4%	-$20.2M-2.7%	-$19.7M-6.2%	-$18.5M-45.5%	-$12.7M
Interest Expense	N/A	N/A	N/A	N/A	$1.3M-33.0%	$2.0M
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A
Net Income	-$31.4M-118.3%	-$14.4M+27.8%	-$19.9M-1.6%	-$19.6M+0.9%	-$19.8M-34.9%	-$14.7M
EPS (Diluted)	$-2.73-108.4%	$-1.31+33.2%	$-1.96+6.2%	$-2.09	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Revenue	$14.3M+2.7%	$13.9M-1.6%	$14.2M-15.4%	$16.7M+32.4%	$12.6M+19.3%	$10.6M-12.5%	$12.1M+23.6%	$9.8M
Cost of Revenue	$8.3M+19.8%	$6.9M-1.7%	$7.0M-26.9%	$9.6M+65.3%	$5.8M+18.3%	$4.9M-29.2%	$7.0M+41.4%	$4.9M
Gross Profit	$6.0M-14.1%	$7.0M-1.4%	$7.1M+0.2%	$7.1M+4.3%	$6.8M+20.3%	$5.7M+10.0%	$5.1M+5.6%	$4.9M
R&D Expenses	$1.4M-4.1%	$1.4M-7.1%	$1.5M+14.9%	$1.3M-1.0%	$1.3M-6.6%	$1.4M-1.3%	$1.5M-4.2%	$1.5M
SG&A Expenses	$12.0M+3.1%	$11.7M+4.6%	$11.1M+63.2%	$6.8M+0.7%	$6.8M-0.2%	$6.8M+6.6%	$6.4M+24.6%	$5.1M
Operating Income	-$7.6M-20.5%	-$6.3M-8.6%	-$5.8M-348.8%	-$1.3M+75.6%	-$5.3M-85.3%	-$2.9M+3.7%	-$3.0M-45.1%	-$2.0M
Interest Expense	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	$0	$0	$0	$0	$0	$0	N/A	$0
Net Income	-$3.7M-110.5%	-$1.8M+93.5%	-$27.3M-46.2%	-$18.7M-106.8%	-$9.0M-319.2%	-$2.2M+45.1%	-$3.9M-252.9%	$2.6M
EPS (Diluted)	$-0.31-106.7%	$-0.15+93.5%	$-2.32-43.2%	$-1.62-105.1%	$-0.79-315.8%	$-0.19-246.2%	$0.13+156.5%	$-0.23

LNSR Balance Sheet

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Total Assets	$66.3M-4.7%	$69.6M+24.6%	$55.8M-16.0%	$66.5M-16.0%	$79.1M+129.1%	$34.5M
Current Assets	$42.0M-9.6%	$46.4M+37.8%	$33.7M-24.8%	$44.8M-23.2%	$58.4M+239.8%	$17.2M
Cash & Equivalents	$16.3M-21.1%	$20.6M+40.5%	$14.7M-53.6%	$31.6M-22.1%	$40.6M+779.7%	$4.6M
Inventory	$11.4M-27.2%	$15.7M+33.6%	$11.7M+80.9%	$6.5M-51.8%	$13.5M+67.1%	$8.1M
Accounts Receivable	$6.1M+52.1%	$4.0M-33.8%	$6.0M+30.2%	$4.6M+130.5%	$2.0M-40.5%	$3.4M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$61.4M+174.2%	$22.4M+61.7%	$13.9M+19.6%	$11.6M-2.7%	$11.9M-81.7%	$65.1M
Current Liabilities	$15.0M+29.0%	$11.6M+1.8%	$11.4M+31.1%	$8.7M+2.9%	$8.5M+8.1%	$7.8M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$4.9M-85.5%	$33.4M-20.4%	$42.0M-23.5%	$54.9M-18.3%	$67.2M+320.0%	-$30.6M
Retained Earnings	-$143.3M-28.1%	-$111.9M-14.8%	-$97.5M-25.7%	-$77.6M-33.8%	-$58.0M-51.9%	-$38.2M

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Total Assets	$70.2M-0.3%	$70.4M-3.5%	$73.0M+10.0%	$66.3M+8.0%	$61.4M-7.1%	$66.1M-5.0%	$69.6M-1.8%	$70.9M
Current Assets	$44.4M-3.1%	$45.9M-6.8%	$49.2M+17.2%	$42.0M+4.4%	$40.2M-5.2%	$42.4M-8.6%	$46.4M-4.5%	$48.6M
Cash & Equivalents	$7.6M+6.8%	$7.2M-63.4%	$19.5M+20.2%	$16.3M+96.2%	$8.3M-40.6%	$14.0M-32.3%	$20.6M-17.3%	$24.9M
Inventory	$20.6M+7.0%	$19.2M+25.6%	$15.3M+34.1%	$11.4M-36.3%	$17.9M+0.7%	$17.8M+13.6%	$15.7M-10.3%	$17.5M
Accounts Receivable	$5.9M+18.3%	$5.0M-27.6%	$6.9M+13.1%	$6.1M+3.3%	$5.9M+46.5%	$4.0M+0.5%	$4.0M+4.0%	$3.8M
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$82.3M+3.3%	$79.7M-2.0%	$81.3M+32.4%	$61.4M+62.7%	$37.8M+10.1%	$34.3M+53.1%	$22.4M+8.1%	$20.7M
Current Liabilities	$35.7M+18.7%	$30.1M+10.7%	$27.2M+81.1%	$15.0M+44.7%	$10.4M-0.8%	$10.4M-10.2%	$11.6M+5.6%	$11.0M
Long-Term Debt	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	-$25.9M-12.4%	-$23.1M-4.1%	-$22.1M-555.4%	$4.9M-79.4%	$23.6M-25.7%	$31.8M-4.8%	$33.4M-8.1%	$36.4M
Retained Earnings	-$176.1M-2.2%	-$172.4M-1.0%	-$170.6M-19.1%	-$143.3M-16.4%	-$123.1M-7.9%	-$114.0M-1.9%	-$111.9M-3.6%	-$108.0M

LNSR Cash Flow Statement

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Operating Cash Flow	-$2.3M+76.4%	-$9.7M+35.0%	-$14.9M-65.6%	-$9.0M+35.0%	-$13.8M-9.5%	-$12.6M
Capital Expenditures	$156K-33.9%	$236K+105.2%	$115K-67.5%	$354K-3.3%	$366K-5.9%	$389K
Free Cash Flow	-$2.4M+75.4%	-$9.9M+33.9%	-$15.0M-60.6%	-$9.3M+34.1%	-$14.2M-9.1%	-$13.0M
Investing Cash Flow	-$2.2M+48.0%	-$4.2M-3513.9%	-$115K+67.5%	-$354K-8.6%	-$326K+84.4%	-$2.1M
Financing Cash Flow	$78K-99.6%	$19.8M+1092.1%	-$2.0M-651.8%	$361K-99.3%	$50.0M+213.5%	$15.9M
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Operating Cash Flow	-$3.5M+29.7%	-$5.0M+28.0%	-$6.9M-289.7%	$3.7M+196.8%	-$3.8M+28.8%	-$5.3M-1005.6%	-$480K-41.6%	-$339K
Capital Expenditures	$0-100.0%	$77K+1183.3%	$6K+100.0%	$3K-97.3%	$113K+465.0%	$20K-55.6%	$45K+2150.0%	$2K
Free Cash Flow	-$3.5M+30.8%	-$5.1M+26.9%	-$6.9M-290.0%	$3.7M+193.9%	-$3.9M+27.0%	-$5.3M-914.7%	-$525K-54.0%	-$341K
Investing Cash Flow	$4.0M+153.4%	-$7.5M-1510.9%	$531K-73.3%	$2.0M+198.5%	-$2.0M-64.9%	-$1.2M+69.1%	-$4.0M-198150.0%	-$2K
Financing Cash Flow	$0-100.0%	$93K-99.0%	$9.7M+5534.3%	$172K+33.3%	$129K+199.2%	-$130K-189.0%	$146K+171.2%	-$205K
Dividends Paid	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

LNSR Financial Ratios

Metric	FY24	FY23	FY22	FY21	FY20	FY19
Gross Margin	48.3%-1.7pp	50.1%-6.4pp	56.4%+4.7pp	51.7%-1.6pp	53.3%+10.0pp	43.3%
Operating Margin	-19.9%+9.1pp	-29.0%+28.1pp	-57.1%-0.0pp	-57.0%+13.1pp	-70.1%-28.5pp	-41.6%
Net Margin	-58.7%-24.6pp	-34.1%+22.2pp	-56.3%+0.6pp	-56.9%+18.1pp	-75.0%-26.9pp	-48.0%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets	-47.4%-26.7pp	-20.7%+15.0pp	-35.7%-6.2pp	-29.5%-4.5pp	-25.0%+17.4pp	-42.4%
Current Ratio	2.80-1.2	3.99+1.0	2.95-2.2	5.14-1.8	6.90+4.7	2.19
Debt-to-Equity	12.64+12.0	0.67+0.3	0.33+0.1	0.21+0.0	0.18+2.3	-2.13
FCF Margin	-4.5%+18.9pp	-23.5%+18.9pp	-42.3%-15.3pp	-27.1%+26.6pp	-53.7%-11.1pp	-42.5%

Metric	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23
Gross Margin	42.2%-8.3pp	50.4%+0.1pp	50.3%+7.8pp	42.5%-11.4pp	53.9%+0.4pp	53.5%+11.0pp	42.5%-7.3pp	49.8%
Operating Margin	-52.9%-7.8pp	-45.1%-4.2pp	-40.9%-33.2pp	-7.7%+34.1pp	-41.8%-14.9pp	-26.9%-2.5pp	-24.5%-3.6pp	-20.8%
Net Margin	-25.9%-13.3pp	-12.7%+180.5pp	-193.1%-81.4pp	-111.8%-40.2pp	-71.6%-51.2pp	-20.4%+12.1pp	-32.4%-58.7pp	26.2%
Return on Equity	N/A	N/A	N/A	N/A	N/A	N/A	N/A	7.1%
Return on Assets	-5.3%-2.8pp	-2.5%+35.0pp	-37.5%-9.3pp	-28.2%-13.5pp	-14.7%-11.5pp	-3.3%+2.4pp	-5.6%-9.3pp	3.6%
Current Ratio	1.24-0.3	1.52-0.3	1.81-1.0	2.80-1.1	3.88-0.2	4.06+0.1	3.99-0.4	4.42
Debt-to-Equity	-3.18+0.3	-3.46+0.2	-3.67-16.3	12.64+11.0	1.60+0.5	1.08+0.4	0.67+0.1	0.57
FCF Margin	-24.5%+11.9pp	-36.4%+12.6pp	-49.0%-70.9pp	21.8%+52.6pp	-30.8%+19.5pp	-50.3%-46.0pp	-4.3%-0.9pp	-3.5%

Similar Companies

Sight Sciences, Inc. SGHT

$283.4M

Accuray Incorp ARAY

$62.1M

Maxcyte MXCT

$76.8M

Profound Med Corp PROF

$239.5M

Rapid Micro Biosystems, Inc. RPID

$173.3M

Frequently Asked Questions

What is Lensar Inc's annual revenue?

Lensar Inc (LNSR) reported $53.5M in total revenue for fiscal year 2024. This represents a 26.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Lensar Inc's revenue growing?

Lensar Inc (LNSR) revenue grew by 26.9% year-over-year, from $42.2M to $53.5M in fiscal year 2024.

Is Lensar Inc profitable?

No, Lensar Inc (LNSR) reported a net income of -$31.4M in fiscal year 2024, with a net profit margin of -58.7%.

What is Lensar Inc's earnings per share (EPS)?

Lensar Inc (LNSR) reported diluted earnings per share of $-2.73 for fiscal year 2024. This represents a -108.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

What is Lensar Inc's EBITDA?

Lensar Inc (LNSR) had EBITDA of -$6.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.

What is Lensar Inc's gross margin?

Lensar Inc (LNSR) had a gross margin of 48.3% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.

What is Lensar Inc's operating margin?

Lensar Inc (LNSR) had an operating margin of -19.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.

What is Lensar Inc's net profit margin?

Lensar Inc (LNSR) had a net profit margin of -58.7% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.

What is Lensar Inc's free cash flow?

Lensar Inc (LNSR) generated -$2.4M in free cash flow during fiscal year 2024. This represents a 75.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Lensar Inc's operating cash flow?

Lensar Inc (LNSR) generated -$2.3M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.

What are Lensar Inc's total assets?

Lensar Inc (LNSR) had $66.3M in total assets as of fiscal year 2024, including both current and long-term assets.

What are Lensar Inc's capital expenditures?

Lensar Inc (LNSR) invested $156K in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.

How much does Lensar Inc spend on research and development?

Lensar Inc (LNSR) invested $5.3M in research and development during fiscal year 2024.

How many shares does Lensar Inc have outstanding?

Lensar Inc (LNSR) had 12M shares outstanding as of fiscal year 2024.

What is Lensar Inc's current ratio?

Lensar Inc (LNSR) had a current ratio of 2.80 as of fiscal year 2024, which is generally considered healthy.

What is Lensar Inc's debt-to-equity ratio?

Lensar Inc (LNSR) had a debt-to-equity ratio of 12.64 as of fiscal year 2024, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Lensar Inc's return on assets (ROA)?

Lensar Inc (LNSR) had a return on assets of -47.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.

What is Lensar Inc's cash runway?

Based on fiscal year 2024 data, Lensar Inc (LNSR) had $16.3M in cash against an annual operating cash burn of $2.3M. This gives an estimated cash runway of approximately 86 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

What is Lensar Inc's Piotroski F-Score?

Lensar Inc (LNSR) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Lensar Inc's earnings high quality?

Lensar Inc (LNSR) has an earnings quality ratio of 0.07x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Lensar Inc?

Lensar Inc (LNSR) scores 38 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.